Trade Summary

6 days ago, Ramasastry Saira, serving as Dir at Mirum Pharmaceuticals, Inc. (MIRM), sold 2,000 shares at $109.47 per share, for a total transaction value of $218,940.00.

This sale represents a 100.00% decrease in Ramasastry Saira's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 8:32 PM ET, 3 days after the trade was made.

Mirum Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.